Fig. 1From: Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors Flow chart of inclusion of patients. HF, heart failure; BMI, body mass indexBack to article page